The 2025 San Antonio Breast Cancer Symposium (SABCS) has emerged as a pivotal platform highlighting breakthroughs in breast cancer research, clinical trials, and therapeutic innovation. Presentations this year emphasized novel targeted therapies, immuno-oncology strategies, and precision medicine approaches, reflecting a shift toward personalized patient care. Pharmaceutical stakeholders, biotech investors, and healthcare analysts are closely monitoring these developments for both clinical impact and commercial potential.